SACS
Summary: This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that 'the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins' (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| sacsin molecular chaperone | MIM:604490 | Ensembl:ENSG00000151835 | HGNC:HGNC:10519 | PA34927 | 13q12.12 |
Gene Categories:
DRUGGABLE GENOMEGO terms in SACS
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | NAS | GO:0006457 | protein folding |
| BP | IMP | GO:0090084 | negative regulation of inclusion body assembly |
| CC | IDA | GO:0005634 | nucleus |
| CC | IDA | GO:0005737 | cytoplasm |
| CC | IDA | GO:0005739 | mitochondrion |
| CC | TAS | GO:0030424 | axon |
| CC | TAS | GO:0030425 | dendrite |
| CC | TAS | GO:0070852 | cell body fiber |
| MF | IPI | GO:0030544 | Hsp70 protein binding |
| MF | IDA | GO:0051087 | chaperone binding |
| MF | IPI | GO:0070628 | proteasome binding |
Gene expression in normal tissue: SACS
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in SACS
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD594 | AZD-8055 | 1 |
| iGMDRD698 | Neratinib | 2 |
| iGMDRD541 | SNX-2112 (PF-04928473) | 1 |
| iGMDRD945 | ML214 | 6 |
| iGMDRD883 | CIL55A | 1 |
| iGMDRD154 | NSC23766 | 3 |
| iGMDRD123 | Isoevodiamine | 4 |
| iGMDRD251 | ML162 | 1 |
| iGMDRD137 | Indisulam | 5 |
| iGMDRD202 | Curcumin | 6 |
| iGMDRD103 | SN-38 | 2 |
| iGMDRD311 | Dacinostat | 1 |
| iGMDRD655 | SCHEMBL618594 | 1 |
| iGMDRD705 | Nakiterpiosin | 1 |
| iGMDRD289 | Parthenolide | 8 |
| iGMDRD329 | Merck60 | 4 |
| iGMDRD286 | Nsc 632839 | 5 |
| iGMDRD871 | BRD6368 | 5 |
| iGMDRD322 | FK 866 | 2 |
| iGMDRD420 | Leucascandrolide A | 6 |
| iGMDRD12 | Bicalutamide | 1 |
| iGMDRD889 | Compound 7d-cis | 4 |
| iGMDRD151 | CHM-1 | 4 |
| iGMDRD433 | Lexibulin | 1 |
| iGMDRD126 | Tipifarnib | 9 |
| iGMDRD484 | Pluripotin | 3 |
| iGMDRD781 | Sirolimus | 7 |
| iGMDRD483 | SCH-529074 | 2 |
| iGMDRD546 | BMS-754807 | 2 |
| iGMDRD670 | ML 210 | 2 |
| iGMDRD152 | 179324-69-7 | 4 |
| iGMDRD61 | Kinetin riboside | 2 |
| iGMDRD687 | I-BET151 | 1 |
| iGMDRD394 | BX-795 | 2 |
| iGMDRD260 | FQI-2 | 2 |
| iGMDRD474 | Avrainvillamide | 4 |
| iGMDRD513 | BML-259 | 2 |
| iGMDRD187 | BRD9876 | 3 |
| iGMDRD171 | Pemetrexed | 4 |
| iGMDRD391 | OSU-03012 | 1 |
| iGMDRD506 | Fedratinib | 2 |
| iGMDRD74 | Idarubicin | 2 |
| iGMDRD188 | Piperlongumine | 4 |
| iGMDRD356 | PNU-74654 | 5 |
| iGMDRD64 | Parbendazole | 5 |
| iGMDRD369 | TGX-115 | 2 |
| iGMDRD512 | nutlin 3 | 2 |
| iGMDRD486 | Tosedostat | 3 |
| iGMDRD307 | Manumycin A | 2 |
| iGMDRD262 | KU-55933 | 1 |
| iGMDRD84 | Lovastatin acid | 4 |
| iGMDRD614 | Dabrafenib | 1 |
| iGMDRD499 | PDMP | 1 |
| iGMDRD351 | GW843682X | 2 |
| iGMDRD435 | BI-2536 | 4 |
| iGMDRD211 | (1S,3R)-RSL3 | 3 |
| iGMDRD901 | ELCPK | 3 |
| iGMDRD267 | Oligomycin A | 6 |
| iGMDRD434 | BMS-536924 | 1 |
| iGMDRD872 | BRD7137 | 3 |
| iGMDRD414 | MST-312 | 7 |
| iGMDRD42 | Vorinostat | 6 |
| iGMDRD353 | PD0325901 | 1 |
| iGMDRD246 | NPC26 | 2 |
| iGMDRD886 | Compound 1541A | 2 |
| iGMDRD300 | Tozasertib | 5 |
| iGMDRD505 | Pevonedistat | 3 |
| iGMDRD1008 | SR-II-138A | 2 |
| iGMDRD599 | Salermide | 2 |
| iGMDRD387 | CHIR-99021 | 1 |
| iGMDRD144 | NSC95397 | 9 |
| iGMDRD193 | Fqi1 | 2 |
| iGMDRD446 | LY 2183240 | 3 |
| iGMDRD608 | Refametinib | 1 |
| iGMDRD130 | Enzastaurin | 1 |
| iGMDRD218 | XAV 939 | 1 |
| iGMDRD634 | SCHEMBL2608041 | 5 |
| iGMDRD802 | 4-methylfasudil | 1 |
| iGMDRD736 | UNC1215 | 1 |
| iGMDRD138 | PX 12 | 3 |
| iGMDRD574 | Ruxolitinib | 1 |
| iGMDRD870 | BRD63610 | 1 |
| iGMDRD885 | Compound 110 | 6 |
| iGMDRD562 | Navitoclax | 3 |
| iGMDRD577 | BIX01294 | 4 |
| iGMDRD100 | Zebularine | 5 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in SACS

